» Articles » PMID: 16258927

Lessons Learned from Nine Clinical Trials of Disease-modifying Osteoarthritis Drugs

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 2005 Nov 1
PMID 16258927
Citations 15
Authors
Affiliations
Soon will be listed here.
Citing Articles

Structural phenotypes of knee osteoarthritis: potential clinical and research relevance.

Roemer F, Jarraya M, Collins J, Kwoh C, Hayashi D, Hunter D Skeletal Radiol. 2022; 52(11):2021-2030.

PMID: 36161341 PMC: 10509066. DOI: 10.1007/s00256-022-04191-6.


Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: post-hoc analysis of a randomised, placebo-controlled phase II clinical trial.

Eckstein F, Kraines J, Aydemir A, Wirth W, Maschek S, Hochberg M Ann Rheum Dis. 2020; 79(4):525-528.

PMID: 32098758 PMC: 7147175. DOI: 10.1136/annrheumdis-2019-216453.


Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial.

Hochberg M, Guermazi A, Guehring H, Aydemir A, Wax S, Fleuranceau-Morel P JAMA. 2019; 322(14):1360-1370.

PMID: 31593273 PMC: 6784851. DOI: 10.1001/jama.2019.14735.


The role of radiography and MRI for eligibility assessment in DMOAD trials of knee OA.

Roemer F, Kwoh C, Hayashi D, Felson D, Guermazi A Nat Rev Rheumatol. 2018; 14(6):372-380.

PMID: 29752462 PMC: 6008101. DOI: 10.1038/s41584-018-0010-z.


Emerging Treatment Models in Rheumatology: Challenges for Osteoarthritis Trials.

Felson D, Neogi T Arthritis Rheumatol. 2018; 70(8):1175-1181.

PMID: 29609224 PMC: 6105531. DOI: 10.1002/art.40515.